ARCHIVES

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Wittes To Become Acting DCT Director; Kaufman Leaves NCI For Private Practice

February 17, 1995

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs

July 11, 1975

ACS, SU2C Committ $20 Million For Lung Cancer Dream Team

January 31, 2014

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004